期刊文献+

Caco-2细胞单层研究淫羊藿黄酮类成分的吸收转运 被引量:32

Absorption and transportation of flavonoids in Herb Epimedii across Caco-2 monolayer model
原文传递
导出
摘要 目的研究淫羊藿黄酮类成分在Caco-2细胞模型中的吸收转运。方法采用超高压液相法测定药物浓度,计算表观渗透系数(Papp),研究淫羊藿黄酮5个主要成分淫羊藿苷、朝藿定A、朝藿定B、朝藿定C、宝藿苷Ⅰ在Caco-2细胞模型中的双向转运。结果淫羊藿苷、朝藿定A、朝藿定B、朝藿定C的吸收渗透系数(PAB)较小,分别为5.91×10-7、3.22×10-7、2.76×10-7、4.23×10-7cm/s,宝藿苷Ⅰ相对较大,为1.46×10-6cm/s;5个化合物的分泌渗透系数(PBA)都比其相应的吸收渗透系数要大,其中宝藿苷Ⅰ的分泌渗透系数是其吸收渗透系数的9.8倍。结论淫羊藿黄酮类成分的肠道吸收较差,可能存在肠道转运蛋白的外排机制,其中三糖苷(朝藿定A、朝藿定B、朝藿定C)的吸收要小于二糖苷(淫羊藿苷),二糖苷的吸收要小于单糖苷(宝藿苷Ⅰ)。 Objective To study the absorption and transportation of flavonoids in Herb Epimedii by using Caco-2 monolayer model. Methods Caco-2 cell monolayer model was used to study the bi-direction transport of icariin, epimedin A, epimedin B, epimedin C, and baohuoside I. The concentration of the five flavonoids in cell culture medium was measured by UPLC and the apparent permeability coefficients (Papp) were calculated. Results The absorptive permeability coefficients (PAB) of icariin, epimedin A, epimedinB, epimedinC, andbaohuoside I were 5.91×10^-7, 3.22×10^-7, 2.76×10^-7, 4.23×10^-7, and 1.46 × 10^-6 cm/s, respectively. Except baohuoside I , the other four flavonodes had lower permeabilities, and the secretive' permeabilities (PBA) of all the flavonoids were larger than their absorptive permeabilities. Among them, the PBA of baohuoside I was 9.8 times as much as the PAB. Conclusion The results suggest that the intestinal absorption of the five flavonoids is lower, which might have efflux mechanism by transporters, and the absorption of monloglycoside (e. g. baohuoside I ) is better than that of diglycoside (e. g. icariin) and triglycoside (e. g. epimedin A, epimedin B, and epimedin C).
出处 《中草药》 CAS CSCD 北大核心 2009年第2期220-224,共5页 Chinese Traditional and Herbal Drugs
基金 国家自然科学基金资助项目(30572372)
关键词 淫羊藿黄酮 CACO-2细胞单层模型 淫羊藿苷 渗透系数 flavonoids in Herb Epimedii Caco-2 cell monolayer model icariin permeability coefficients
  • 相关文献

参考文献12

  • 1黄秀兰,周亚伟,王伟.淫羊藿黄酮类化合物药理研究进展[J].中成药,2005,27(6):719-721. 被引量:92
  • 2李梨,周岐新,石京山.淫羊藿苷药理作用研究进展[J].中国药房,2005,16(12):952-954. 被引量:52
  • 3Hidalg I J, Raub T J, Borchadt R T. Characterization of the human colon carcinoma, cell line (Caco-2) as a model system for intestinal epithelial permeability [J]. Gasteoenterology, 1989,96:736.
  • 4Hu M, Chen J, Tran D, et al. The Caco-2 cell monolayers as an intestinal metabolism model: metabolism of dipeptide Phe-Pro [J]. Drug Target, 1994,2 : 79.
  • 5Hu M, Chen J, Zhu Y, et al. Mechanism and kinetics of transcellular transport of a new β-actam antibiotic loracarbef across an human intestinal epithelial model system (Caeo-2) [J]. Pharm Res, 1994,11: 1405.
  • 6Yan Z Y, Gary W. Optimization in Dug Discovery in vitro Methods [M]. Totowa: Hurnana Press Inc. ,2004.
  • 7Chen J, Lin H M, Hu M. Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model [J]. Cancer Chemother Pharrnacol, 2005, 55:159.
  • 8Artursson P, Karlsson J. Correlation between oral drug absorptionin humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells [J]. Biochem Biophys Res Comrnun ,1991,175(3) :880.
  • 9Ye L K, Chen J M, Liu S H, etal Pharmacokinetics of icariininrats [J]. ChinPharm J, 1999,34(1) :33.
  • 10Eun J J, Liu X, Jia X B, etal. Coupling of conjugating enzymes and effiux transporters: impact on bioavailability and drug interactions [J]. Curt Drug Metabol,2005(6) :455.

二级参考文献42

共引文献140

同被引文献389

引证文献32

二级引证文献266

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部